Opioid Antagonist  ·  Relapse Prevention Medicine

Naltrexone

Also known as: Revia, Antaxone

A medicine for preventing relapse in people who have completed detoxification from opioids or alcohol, not a detox medicine itself, but a support for the recovery that follows.

ATC CodeN07BB04
Kenya EML 2023Listed
Level of UseLevel 4-6
This is health education, not medical advice. Never start, stop, or change a medication without speaking to a qualified healthcare professional first.
⚠️
Prescription Only: Full Detoxification Required Before Starting

Starting naltrexone before being fully opioid-free for at least seven to ten days will cause immediate severe withdrawal.

Which conditions is Naltrexone used for?

What is Naltrexone?

Naltrexone is used to help people maintain abstinence from opioids or alcohol after completing detoxification. It completely blocks opioid receptors so that if opioids are used, they produce no effect.

For alcohol use disorder, it reduces the pleasure and craving associated with drinking, making it easier to maintain abstinence or reduce consumption.

It is listed in Kenya's Essential Medicines List 2023. It works best as part of a broader plan that includes psychosocial support, counselling, and community engagement.

What does it do in the brain?

Naltrexone blocks opioid receptors throughout the brain completely and competitively, preventing opioids or alcohol-triggered endorphins from activating them. If opioids are taken while naltrexone is active, they have no effect. This removes the reward that drives continued use and reduces craving over time.

How is it available?

Tablet
50 mg
Taken by mouth
Available at Level 4 to 6 and specialist addiction services

Where is it available in Africa and what is it called?

Names and availability vary by country. Always confirm with a local pharmacist or healthcare provider.
CountryCommon Brand Name(s)Notes
South AfricaRevia, Naltrexone (generic)Available on prescription for alcohol and opioid use disorder; stocked at addiction treatment centres.
NigeriaRevia, Naltrexone (generic)Available at teaching hospital pharmacies and private addiction clinics in major cities.
GhanaNaltrexone (generic)Available at Korle-Bu Teaching Hospital and select private pharmacies in Accra.
UgandaNaltrexone (generic)Available at Butabika Hospital and through some private addiction services in Kampala.
TanzaniaNaltrexone (generic)Available at Muhimbili National Hospital for post-detox relapse prevention.

What might you feel while taking it?

These are the most commonly reported effects. Not everyone experiences them, and many settle within the first few weeks.

  • Nausea and abdominal discomfort, particularly in the first week
  • Reduced appetite
  • Headache
  • Fatigue and difficulty sleeping
  • Low mood in some people, particularly in the early weeks
Go to a doctor or emergency room straight away if you notice any of the following.
  • If started before being fully free of opioids, naltrexone causes immediate and intense opioid withdrawal, severe and dangerous
  • Liver inflammation at very high doses, liver function is checked before starting
  • Some people notice low mood in the early weeks, report this to your doctor

Important warnings before starting

Tell your doctor about all your medical conditions, allergies, and other medicines before starting Naltrexone.
  • Currently using opioids or not yet fully detoxified
  • Significant liver failure
  • Currently taking any opioid-containing medicine

Situations that need extra attention

  • Carry information explaining that you are on naltrexone. If you need emergency pain relief, opioid painkillers will not work while naltrexone is active
  • After stopping naltrexone, opioid tolerance is reduced. If you relapse, the amount that would previously have been manageable could now cause an overdose.
  • Tell your doctor about any liver disease
  • Consistent daily use produces the relapse prevention benefit
Pregnancy
Limited data. Discuss with your doctor if pregnancy is possible or confirmed.
Breastfeeding
Insufficient data. Specialist guidance required.

Medicines and substances that can interact with it

Always tell your doctor and pharmacist about every medicine, supplement, and herbal remedy you take, including those bought without a prescription.
  • All opioid medicines including codeine, tramadol, morphine: Naltrexone blocks their effect entirely. Pain management during treatment must use non-opioid approaches.
  • Opioid-containing cough and diarrhoea medicines: These will not work while naltrexone is active.

What your doctor will monitor

  • Liver function tests before starting and periodically during treatment
  • Mood and mental health, particularly in the first month
  • Adherence and motivation at each appointment
  • A urine test before starting to confirm opioid-free status

What happens if you stop taking it?

Naltrexone can generally be stopped without tapering. However, stopping significantly reduces opioid tolerance. If you are stopping and have any history of opioid use, you and those around you should be aware of this risk.

What you should know about this medicine in Kenya

Naltrexone offers an important option in Kenya's addiction treatment landscape for people who have completed detoxification and are committed to abstinence.

For alcohol use disorder, a condition with a significant and growing burden in Kenya, naltrexone is an evidence-based option that is underused. It works best alongside counselling and social support.

People using naltrexone should be counselled clearly about the change in opioid tolerance that occurs after stopping, particularly given the risk of overdose if relapse follows a period of abstinence.

References

  1. Ministry of Health, Kenya. (2023). Kenya Essential Medicines List 2023. Nairobi: Ministry of Health.
  2. Ministry of Health, Kenya. (2023). Kenya National Medicines Formulary, 1st Edition. Nairobi: Ministry of Health.
  3. World Health Organization. (2023). Model List of Essential Medicines, 23rd Edition. Geneva: WHO.
  4. Anton, R. F., et al. (2006). Combined pharmacotherapies and behavioral interventions for alcohol dependence. JAMA, 295(17), 2003-2017.